MicroRNAs in metabolism

Acta Physiologica

Volumn 219, Issue 2, 2017, Pages 346-361

  Vienberg, S ^a   Geiger, J ^b   Madsen, S ^a   Dalgaard, L T ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ROSKILDE UNIVERSITY   (Denmark)

Author keywords

adipocytes; metabolism; microRNA; non alcoholic hepato steatosis; type 2 diabetes mellitus; cells

Indexed keywords

ABC TRANSPORTER A1; ARGONAUTE 2 PROTEIN; BIOLOGICAL MARKER; DICER; INSULIN; MICRORNA; MICRORNA 1; MICRORNA 103; MICRORNA 107; MICRORNA 122; MICRORNA 126; MICRORNA 133; MICRORNA 141; MICRORNA 143; MICRORNA 155; MICRORNA 200; MICRORNA 200A; MICRORNA 200C; MICRORNA 206; MICRORNA 29; MICRORNA 335; MICRORNA 33A; MICRORNA 33B; MICRORNA 34A; MICRORNA 365; MICRORNA 375; MICRORNA 455; MICRORNA 7; RIBONUCLEASE III; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; CARDIAC MUSCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; EXOCYTOSIS; EXOSOME; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIVER METABOLISM; METABOLIC DISORDER; METABOLIC REGULATION; METABOLIC SYNDROME X; METABOLISM; MUSCLE DEVELOPMENT; MUSCLE METABOLISM; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; SKELETAL MUSCLE CELL; ANIMAL; GENETICS; HOMEOSTASIS; PHYSIOLOGY;

ANIMALS; HOMEOSTASIS; HUMANS; METABOLISM; MICRORNAS;

EID: 84963614519     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12681     Document Type: Review

References (134)

1. Aguda, B.D., Kim, Y., Piper-Hunter, M.G., Friedman, A. & Marsh, C.B. 2008. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105, 19678–19683.
2. Arner, P. & Kulyte, A. 2015. MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol 11, 276–288.
3. Arner, E., Mejhert, N., Kulyte, A., Balwierz, P.J., Pachkov, M., Cormont, M., Lorente-Cebrian, S., Ehrlund, A., Laurencikiene, J., Heden, P. et al. 2012. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 61, 1986–1993.
4. Arrese, M., Eguchi, A. & Feldstein, A.E. 2015. Circulating microRNAs: emerging biomarkers of liver disease. Semin Liver Dis 35, 43–54.
5. Arroyo, J.D., Chevillet, J.R., Kroh, E.M., Ruf, I.K., Pritchard, C.C., Gibson, D.F., Mitchell, P.S., Bennett, C.F., Pogosova-Agadjanyan, E.L., Stirewalt, D.L., Tait, J.F. & Tewari, M. 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108, 5003–5008.
6. Ban, J.-J., Lee, M., Im, W. & Kim, M. 2015. Low pH increases the yield of exosome isolation. Biochem Biophys Res Commun 461, 76–79.
7. Banerjee, J. & Sen, C.K. 2015. microRNA and wound healing. Adv Exp Med Biol 888, 291–305.
8. Belgardt, B.F., Ahmed, K., Spranger, M., Latreille, M., Denzler, R., Kondratiuk, N., von Meyenn, F., Villena, F.N., Herrmanns, K., Bosco, D., Kerr-Conte, J., Pattou, F., Rulicke, T. & Stoffel, M. 2015. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nat Med 21, 619–627.
9. Bhatt, K., Kato, M. & Natarajan, R. 2016. Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases. Am J Physiol Renal Physiol 310, F109–F118.
10. Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M. & Dahlsveen, I.K. 2013. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59, S1–S6.
11. Bodine, S.C. 2013. Disuse-induced muscle wasting. Int J Biochem Cell Biol 45, 2200–2208.
12. Boon, H., Sjogren, R.J., Massart, J., Egan, B., Kostovski, E., Iversen, P.O., Hjeltnes, N., Chibalin, A.V., Widegren, U. & Zierath, J.R. 2015. MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression. Physiol Rep 3, e12622, doi: 10.14814/phy2.12622.
13. van de Bunt, M., Gaulton, K.J., Parts, L., Moran, I., Johnson, P.R., Lindgren, C.M., Ferrer, J., Gloyn, A.L. & McCarthy, M.I. 2013. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE 8, e55272.
14. Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J. & Wittwer, C.T. 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55, 611–622.
15. Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.L., Segnalini, P., Gu, Y., Dalton, N.D. et al. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13, 613–618.
16. Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L. & Wang, D.Z. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38, 228–233.
17. Chen, J.F., Murchison, E.P., Tang, R., Callis, T.E., Tatsuguchi, M., Deng, Z., Rojas, M., Hammond, S.M., Schneider, M.D., Selzman, C.H., Meissner, G., Patterson, C., Hannon, G.J. & Wang, D.Z. 2008. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 105, 2111–2116.
18. Chen, Y., Siegel, F., Kipschull, S., Haas, B., Frohlich, H., Meister, G. & Pfeifer, A. 2013. miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun 4, 1769.
19. Chen, Y., Gao, D.Y. & Huang, L. 2015. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev 81, 128–141.
20. Chevillet, J.R., Kang, Q., Ruf, I.K., Briggs, H.A., Vojtech, L.N., Hughes, S.M., Cheng, H.H., Arroyo, J.D., Meredith, E.K., Gallichotte, E.N. et al. 2014. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA 111, 14888–14893.
21. Da Costa Martins, P.A., Salic, K., Gladka, M.M., Armand, A.S., Leptidis, S., El Azzouzi, H., Hansen, A., Coenen-De Roo, C.J., Bierhuizen, M.F., Van Der Nagel, R. et al. 2010. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12, 1220–1227.
22. Dayeh, T., Volkov, P., Salo, S., Hall, E., Nilsson, E., Olsson, A.H., Kirkpatrick, C.L., Wollheim, C.B., Eliasson, L., Ronn, T., Bacos, K. & Ling, C. 2014. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet 10, e1004160.
23. DeFronzo, R.A., Gunnarsson, R., Bjorkman, O., Olsson, M. & Wahren, J. 1985. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76, 149–155.
24. Dey, B.K., Gagan, J. & Dutta, A. 2011. miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 31, 203–214.
25. Dirkx, E., Gladka, M.M., Philippen, L.E., Armand, A.S., Kinet, V., Leptidis, S., El Azzouzi, H., Salic, K., Bourajjaj, M., Da Silva, G.J. et al. 2013. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol 15, 1282–1293.
26. Dumortier, O., Hinault, C. & van Obberghen, E. 2013. MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 18, 312–324.
27. Ekimler, S., Sahin, K., Watanabe, Y., Tomita, M. & Kanai, A. 2014. Computational methods for microRNA target prediction. Methods Enzymol 5, 671–683.
28. Eliasson, L. 2014. The exocytotic machinery. Acta Physiol (Oxf) 210, 455–457.
29. Elmen, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., Hedtjarn, M., Hansen, J.B., Hansen, H.F., Straarup, E.M., McCullagh, K., Kearney, P. & Kauppinen, S. 2007. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36, 1153–1162.
30. Erener, S., Mojibian, M., Fox, J.K., Denroche, H.C. & Kieffer, T.J. 2013. Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice. Endocrinology 154, 603–608.
31. Esau, C., Davis, S., Murray, S.F., Yu, X.X., Pandey, S.K., Pear, M., Watts, L., Booten, S.L., Graham, M., McKay, R. et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87–98.
32. Esguerra, J.L., Bolmeson, C., Cilio, C.M. & Eliasson, L. 2011. Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS ONE 6, e18613.
33. Fernandez-Hernando, C., Ramirez, C.M., Goedeke, L. & Suarez, Y. 2013. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 33, 178–185.
34. Feuermann, Y., Kang, K., Gavrilova, O., Haetscher, N., Jang, S.J., Yoo, K.H., Jiang, C., Gonzalez, F.J., Robinson, G.W. & Hennighausen, L. 2013. MiR-193b and miR-365-1 are not required for the development and function of brown fat in the mouse. RNA Biol 10, 1807–1814.
35. Ganesan, J., Ramanujam, D., Sassi, Y., Ahles, A., Jentzsch, C., Werfel, S., Leierseder, S., Loyer, X., Giacca, M., Zentilin, L., Thum, T., Laggerbauer, B. & Engelhardt, S. 2013. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 127, 2097–2106.
36. Gebert, L.F.R., Rebhan, M.A.E., Crivelli, S.E.M., Denzler, R., Stoffel, M. & Hall, J. 2014. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res 42, 609–621.
37. Goedeke, L., Rotllan, N., Canfran-Duque, A., Aranda, J.F., Ramirez, C.M., Araldi, E., Lin, C.S., Anderson, N.N., Wagschal, A., de Cabo, R., Horton, J.D., Lasuncion, M.A., Naar, A.M., Suarez, Y. & Fernandez-Hernando, C. 2015. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels. Nat Med 21, 1280–1289.
38. Halban, P.A., Polonsky, K.S., Bowden, D.W., Hawkins, M.A., Ling, C., Mather, K.J., Powers, A.C., Rhodes, C.J., Sussel, L. & Weir, G.C. 2014. Beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab 99, 1983–1992.
39. Hayes, J., Peruzzi, P.P. & Lawler, S. 2014. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20, 460–469.
40. Hellemans, J. & Vandesompele, J. 2014. Selection of reliable reference genes for RT-qPCR analysis. Methods Mol Biol 1160, 19–26.
41. Heneghan, H.M., Miller, N., McAnena, O.J., O'Brien, T. & Kerin, M.J. 2011. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab 96, E846–E850.
42. Henke, J.I., Goergen, D., Zheng, J., Song, Y., Schüttler, C.G., Fehr, C., Jünemann, C. & Niepmann, M. 2008. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27, 3300–3310.
43. + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49, 424–430.
44. Horie, T., Ono, K., Horiguchi, M., Nishi, H., Nakamura, T., Nagao, K., Kinoshita, M., Kuwabara, Y., Marusawa, H., Iwanaga, Y., Hasegawa, K., Yokode, M., Kimura, T. & Kita, T. 2010. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA 107, 17321–17326.
45. Hutson, M.R. & Kirby, M.L. 2007. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin Cell Dev Biol 18, 101–110.
46. Jacovetti, C., Matkovich, S.J., Rodriguez-Trejo, A., Guay, C. & Regazzi, R. 2015. Postnatal beta-cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning. Nat Commun 6, 8084.
47. Janssen, H.L.A., Reesink, H.W., Lawitz, E.J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A.J., Patick, A.K., Chen, A., Zhou, Y., Persson, R., King, B.D., Kauppinen, S., Levin, A.A. & Hodges, M.R. 2013. Treatment of HCV infection by targeting microRNA. N Engl J Med 368, 1685–1694.
48. Javidi, M.A., Ahmadi, A.H., Bakhshinejad, B., Nouraee, N., Babashah, S. & Sadeghizadeh, M. 2014. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol 31, 295.
49. Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M. & Sarnow, P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577–1581.
50. Jopling, C.L., Schütz, S. & Sarnow, P. 2008. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4, 77–85.
51. Jordan, S.D., Kruger, M., Willmes, D.M., Redemann, N., Wunderlich, F.T., Bronneke, H.S., Merkwirth, C., Kashkar, H., Olkkonen, V.M., Bottger, T., Braun, T., Seibler, J. & Bruning, J.C. 2011. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 13, 434–446.
52. Kalis, M., Bolmeson, C., Esguerra, J.L., Gupta, S., Edlund, A., Tormo-Badia, N., Speidel, D., Holmberg, D., Mayans, S., Khoo, N.K., Wendt, A., Eliasson, L. & Cilio, C.M. 2011. Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS ONE 6, e29166.
53. Keller, P., Gburcik, V., Petrovic, N., Gallagher, I.J., Nedergaard, J., Cannon, B. & Timmons, J.A. 2011. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord 11, 7.
54. Kong, L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., Zhao, J. & Zhao, L. 2010. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48, 61–69.
55. Kornfeld, J.W., Baitzel, C., Konner, A.C., Nicholls, H.T., Vogt, M.C., Herrmanns, K., Scheja, L., Haumaitre, C., Wolf, A.M., Knippschild, U., Seibler, J., Cereghini, S., Heeren, J., Stoffel, M. & Bruning, J.C. 2013. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 494, 111–115.
56. Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K.G., Tuschl, T., Manoharan, M. & Stoffel, M. 2005. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438, 685–689.
57. Kulyte, A., Belarbi, Y., Lorente-Cebrian, S., Bambace, C., Arner, E., Daub, C.O., Heden, P., Ryden, M., Mejhert, N. & Arner, P. 2014. Additive effects of microRNAs and transcription factors on CCL2 production in human white adipose tissue. Diabetes 63, 1248–1258.
58. Kwekkeboom, R.F.J., Sluijter, J.P.G., van Middelaar, B.J., Metz, C.H., Brans, M.A., Kamp, O., Paulus, W.J. & Musters, R.J.P. 2016. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles. J Controlled Release 222, 18–31.
59. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. 2001. Identification of novel genes coding for small expressed RNAs. Science 294, 853–858.
60. Latreille, M., Hausser, J., Stutzer, I., Zhang, Q., Hastoy, B., Gargani, S., Kerr-Conte, J., Pattou, F., Zavolan, M., Esguerra, J.L., Eliasson, L., Rulicke, T., Rorsman, P. & Stoffel, M. 2014. MicroRNA-7a regulates pancreatic beta cell function. J Clin Invest 124, 2722–2735.
61. Latreille, M., Herrmanns, K., Renwick, N., Tuschl, T., Malecki, M.T., McCarthy, M.I., Owen, K.R., Rulicke, T. & Stoffel, M. 2015. miR-375 gene dosage in pancreatic beta-cells: implications for regulation of beta-cell mass and biomarker development. J Mol Med (Berl) 93, 1159–1169.
62. Lee, R.C., Feinbaum, R.L. & Ambros, V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854.
63. Lindow, M., Vornlocher, H.-P., Riley, D., Kornbrust, D.J., Burchard, J., Whiteley, L.O., Kamens, J., Thompson, J.D., Nochur, S., Younis, H., Bartz, S., Parry, J., Ferrari, N., Henry, S.P. & Levin, A.A. 2012. Assessing unintended hybridization-induced biological effects of oligonucleotides. Nat Biotechnol 30, 920–923.
64. Locke, J.M., Da, S.X., Dawe, H.R., Rutter, G.A. & Harries, L.W. 2014. Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia 57, 122–128.
65. Lynn, F.C., Skewes-Cox, P., Kosaka, Y., McManus, M.T., Harfe, B.D. & German, M.S. 2007. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56, 2938–2945.
66. Marquart, T.J., Allen, R.M., Ory, D.S. & Baldan, A. 2010. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 107, 12228–12232.
67. Martinez-Sanchez, A., Nguyen-Tu, M.S. & Rutter, G.A. 2015. DICER inactivation identifies pancreatic beta-cell “disallowed” genes targeted by microRNAs. Mol Endocrinol 29, 1067–1079.
68. Mazière, P. & Enright, A.J. 2007. Prediction of microRNA targets. Drug Discovery Today 12, 452–458.
69. McAlexander, M.A., Phillips, M.J. & Witwer, K.W. 2013. Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid. Front Genet 4, 1–8.
70. McCarthy, J.J., Esser, K.A., Peterson, C.A. & Dupont-Versteegden, E.E. 2009. Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 39, 219–226.
71. Melkman-Zehavi, T., Oren, R., Kredo-Russo, S., Shapira, T., Mandelbaum, A.D., Rivkin, N., Nir, T., Lennox, K.A., Behlke, M.A., Dor, Y. & Hornstein, E. 2011. miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors. EMBO J 30, 835–845.
72. Mestdagh, P., van Vlierberghe, P., de Weer, A., Muth, D., Westermann, F., Speleman, F. & Vandesompele, J. 2009. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10, R64.
73. Mestdagh, P., Hartmann, N., Baeriswyl, L., Andreasen, D., Bernard, N., Chen, C., Cheo, D., D'Andrade, P., Demayo, M., Dennis, L. et al. 2014. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods 11, 809–815.
74. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A. et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513–10518.
75. Moldovan, L., Batte, K.E., Trgovcich, J., Wisler, J., Marsh, C.B. & Piper, M. 2014. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18, 371–390.
76. Mori, M., Nakagami, H., Rodriguez-Araujo, G., Nimura, K. & Kaneda, Y. 2012a. Essential role for miR-196a in brown adipogenesis of white fat progenitor cells. PLoS Biol 10, e1001314.
77. Mori, M.A., Raghavan, P., Thomou, T., Boucher, J., Robida-Stubbs, S., Macotela, Y., Russell, S.J., Kirkland, J.L., Blackwell, T.K. & Kahn, C.R. 2012b. Role of microRNA processing in adipose tissue in stress defense and longevity. Cell Metab 16, 336–347.
78. Mori, M.A., Thomou, T., Boucher, J., Lee, K.Y., Lallukka, S., Kim, J.K., Torriani, M., Yki-Jarvinen, H., Grinspoon, S.K., Cypess, A.M. & Kahn, C.R. 2014. Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy. J Clin Invest 124, 3339–3351.
79. Moura, J., Borsheim, E. & Carvalho, E. 2014. The role of microRNAs in diabetic complications-special emphasis on wound healing. Genes (Basel) 5, 926–956.
80. Musso, G., Cassader, M., Rosina, F. & Gambino, R. 2012. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55, 885–904.
81. Najafi-Shoushtari, S.H., Kristo, F., Li, Y., Shioda, T., Cohen, D.E., Gerszten, R.E. & Naar, A.M. 2010. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566–1569.
82. Obad, S., Santos, C.O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E.M. et al. 2011. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43, 371–378.
83. Ofori, J.K., Salunkhe, V.A., Bagge, A., Wendt, A., Mulder, H., Eliasson, L. & Esguerra, J.L.S. 2014. Regulation of Glucose-Stimulated Insulin Secretion (GSIS) by miR-130a/b and miR-152 via pyruvate dehydrogenase E1 component, alpha subunit PDHA1. Diabetologia 57, S170–S170.
84. O'Rourke, J.R., Georges, S.A., Seay, H.R., Tapscott, S.J., McManus, M.T., Goldhamer, D.J., Swanson, M.S. & Harfe, B.D. 2007. Essential role for Dicer during skeletal muscle development. Dev Biol 311, 359–368.
85. Ortega, F.J., Mercader, J.M., Catalan, V., Moreno-Navarrete, J.M., Pueyo, N., Sabater, M., Gomez-Ambrosi, J., Anglada, R., Fernandez-Formoso, J.A., Ricart, W., Fruhbeck, G. & Fernandez-Real, J.M. 2013. Targeting the circulating microRNA signature of obesity. Clin Chem 59, 781–792.
86. Ottosen, S., Parsley, T.B., Yang, L., Zeh, K., van Doorn, L.-J., van der Veer, E., Raney, A.K., Hodges, M.R. & Patick, A.K. 2015. In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis c virus therapeutic targeting the human factor miR-122. Antimicrob Agents Chemother 59, 599–608.
87. Peterson, S.M., Thompson, J.A., Ufkin, M.L., Sathyanarayana, P., Liaw, L. & Congdon, C.B. 2014. Common features of microRNA target prediction tools. Front Genet 5, 1–10.
88. Polge, C., Heng, A.E., Combaret, L., Bechet, D., Taillandier, D. & Attaix, D. 2013. Recent progress in elucidating signalling proteolytic pathways in muscle wasting: potential clinical implications. Nutr Metab Cardiovasc Dis 23(Suppl. 1), S1–S5.
89. Poy, M.N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P.E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P. & Stoffel, M. 2004. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226–230.
90. Poy, M.N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M. & Stoffel, M. 2009. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 106, 5813–5818.
91. Pullen, T.J., Da, S.X., Kelsey, G. & Rutter, G.A. 2011. miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 31, 3182–3194.
92. Rayner, K.J., Suarez, Y., Davalos, A., Parathath, S., Fitzgerald, M.L., Tamehiro, N., Fisher, E.A., Moore, K.J. & Fernandez-Hernando, C. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570–1573.
93. RegulusTherapeutics, I. 2014. Regulus announces notice of allowance from U.S. patent office related to microRNA-103/107 Program in Metabolic Disorders. Press release, 1.
94. RegulusTherapeutics, I. 2015. RG - 125 (AZD4076), a microRNA therapeutic targeting microRNA - 103/107 for the treatment of NASH in patients with type 2 diabetes/Pre – Diabetes, selected as clinical candidate by AstraZeneca. Press release.
95. Roberts, T.C. 2015. The microRNA machinery. Adv Exp Med Biol 887, 15–30.
96. Rosen, E.D. & Spiegelman, B.M. 2006. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847–853.
97. Rottiers, V. & Naar, A.M. 2012. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13, 239–250.
98. Rutter, G.A. 2014. Dorothy Hodgkin Lecture 2014. Understanding genes identified by genome-wide association studies for type 2 diabetes. Diabet Med 31, 1480–1487.
99. Saito, T. & Sætrom, P. 2010. MicroRNAs – targeting and target prediction. New Biotechnol 27, 243–249.
100. Salunkhe, V.A., Esguerra, J.L., Ofori, J.K., Mollet, I.G., Braun, M., Stoffel, M., Wendt, A. & Eliasson, L. 2015a. Modulation of microRNA-375 expression alters voltage-gated Na(+) channel properties and exocytosis in insulin-secreting cells. Acta Physiol (Oxf) 213, 882–892.
101. 2+-dependent exocytosis in beta cells. Diabetologia 58, S128–S128.
102. Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E. & Ambros, V. 2004. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5, R13.
103. Shu, D., Li, H., Shu, Y., Xiong, G., Carson, W.E., Haque, F., Xu, R. & Guo, P. 2015. Systemic delivery of anti-miRNA for suppression of triple negative breast. ACS Nano 9, 9731–9740.
104. Sjogren, R.J., Egan, B., Katayama, M., Zierath, J.R. & Krook, A. 2015. Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells. Physiol Genomics 47, 45–57.
105. Snider, P., Olaopa, M., Firulli, A.B. & Conway, S.J. 2007. Cardiovascular development and the colonizing cardiac neural crest lineage. ScientificWorldJournal 7, 1090–1113.
106. Sørensen, A., Wissing, M., Salö, S., Englund, A. & Dalgaard, L. 2014. MicroRNAs Related to Polycystic Ovary Syndrome (PCOS). Genes 5, 684–708.
107. Soriano-Arroquia, A., McCormick, R., Molloy, A.P., McArdle, A. & Goljanek-Whysall, K. 2016. Age-related changes in miR-143-3p:Igfbp5 interactions affect muscle regeneration. Aging Cell 15, 361–369.
108. Stenvang, J. & Kauppinen, S. 2008. MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther 8, 59–81.
109. Stenvang, J., Petri, A., Lindow, M., Obad, S. & Kauppinen, S. 2012. Inhibition of microRNA function by antimiR oligonucleotides. Silence 3, 1.
110. Sun, L., Xie, H., Mori, M.A., Alexander, R., Yuan, B., Hattangadi, S.M., Liu, Q., Kahn, C.R. & Lodish, H.F. 2011. Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol 13, 958–965.
111. Suzuki, R., Lee, K., Jing, E., Biddinger, S.B., McDonald, J.G., Montine, T.J., Craft, S. & Kahn, C.R. 2010. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab 12, 567–579.
112. Taft, R.J., Pheasant, M. & Mattick, J.S. 2007. The relationship between non-protein-coding DNA and eukaryotic complexity. BioEssays 29, 288–299.
113. Tattikota, S.G., Rathjen, T., McAnulty, S.J., Wessels, H.H., Akerman, I., van de Bunt, M., Hausser, J., Esguerra, J.L., Musahl, A., Pandey, A.K. et al. 2014. Argonaute2 mediates compensatory expansion of the pancreatic beta cell. Cell Metab 19, 122–134.
114. Tattikota, S.G., Rathjen, T., Hausser, J., Khedkar, A., Kabra, U.D., Pandey, V., Sury, M., Wessels, H.H., Mollet, I.G., Eliasson, L. et al. 2015. miR-184 regulates pancreatic beta-cell function according to glucose metabolism. J Biol Chem 290, 20284–20294.
115. Towbin, J.A. & Bowles, N.E. 2002. The failing heart. Nature 415, 227–233.
116. Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M.H. & Stoffel, M. 2011. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649–653.
117. Trajkovski, M., Ahmed, K., Esau, C.C. & Stoffel, M. 2012. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat Cell Biol 14, 1330–1335.
118. Trevorlstokes 2012. Group retracts microRNA paper after realizing reagent was skewing results. Retraction Watch, 1.
119. Tugay, K., Guay, C., Marques, A.C., Allagnat, F., Locke, J.M., Harries, L.W., Rutter, G.A. & Regazzi, R. 2015. Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets. Diabetologia 59, 161–169.
120. Van Der Ree M.H., van der Meer, A.J., de Bruijne, J., Maan, R., van Vliet, A., Welzel, T.M., Zeuzem, S., Lawitz, E.J., Rodriguez-Torres, M., Kupcova, V., Wiercinska-Drapalo, A., Hodges, M.R., Janssen, H.L.A. & Reesink, H.W. 2014. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antiviral Res 111, 53–59.
121. Van Peer, G., Lefever, S., Anckaert, J., Beckers, A., Rihani, A., Van Goethem, A., Volders, P.J., Zeka, F., Ongenaert, M., Mestdagh, P. & Vandesompele, J. 2014. miRBase tracker: keeping track of microRNA annotation changes. Database (Oxford) pii: bau080. doi: 10.1093/database/bau080.
122. Van Rooij, E., Quiat, D., Johnson, B.A., Sutherland, L.B., Qi, X., Richardson, J.A., Kelm, R.J. Jr & Olson, E.N. 2009. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17, 662–673.
123. Vandesompele, J. 2013. How to find stably expressed microRNAs | Biogazelle.
124. Vlachos, I.S. & Hatzigeorgiou, A.G. 2013. Online resources for miRNA analysis. Clin Biochem 46, 879–890.
125. Wang, H., Jiang, Y., Peng, H., Chen, Y., Zhu, P. & Huang, Y. 2015a. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors. Adv Drug Deliv Rev 81, 142–160.
126. Wang, P., Fiaschi-Taesch, N.M., Vasavada, R.C., Scott, D.K., Garcia-Ocana, A. & Stewart, A.F. 2015b. Diabetes mellitus–advances and challenges in human beta-cell proliferation. Nat Rev Endocrinol 11, 201–212.
127. Witkos, T.M., Koscianska, E. & Krzyzosiak, W.J. 2011. Practical aspects of microRNA target prediction. Curr Mol Med 11, 93–109.
128. Witwer, K.W. 2013. Data submission and quality in microarray-based microRNA profiling. Clin Chem 59, 392–400.
129. Xie, H., Lim, B. & Lodish, H.F. 2009. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58, 1050–1057.
130. Yang, Z., Chen, H., Si, H., Li, X., Ding, X., Sheng, Q., Chen, P. & Zhang, H. 2014. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes. Acta Diabetol 51, 823–831.
131. Zhang, Y., Wang, Z. & Gemeinhart, R.A. 2013. Progress in microRNA delivery. J Controlled Release 172, 962–974.
132. Zhang, H., Guan, M., Townsend, K.L., Huang, T.L., An, D., Yan, X., Xue, R., Schulz, T.J., Winnay, J., Mori, M. et al. 2015. MicroRNA-455 regulates brown adipogenesis via a novel HIF1an-AMPK-PGC1alpha signaling network. EMBO Rep 16, 1378–1393.
133. Zhao, Y., Wang, E., Liu, H., Rotunno, M., Koshiol, J., Marincola, F.M., Landi, M.T. & McShane, L.M. 2010. Evaluation of normalization methods for two-channel microRNA microarrays. J Transl Med 8, 69.
134. Zhou, B., Li, C., Qi, W., Zhang, Y., Zhang, F., Wu, J.X., Hu, Y.N., Wu, D.M., Liu, Y., Yan, T.T., Jing, Q., Liu, M.F. & Zhai, Q.W. 2012. Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia 55, 2032–2043.